EZH2 and neoplasm: Consequently, in addition to the elucidation of the molecular prerequisites predicting anti-tumorigenic consequences of EZH2 blockade, the distinction between canonical and non-canonical EZH2 activities contributing to tumor progression is relevant for the selection of the most efficient pharmacological strategies aiding at EZH2.